UK Clinical Trials Amendment Regulations 2025: What Sponsors Must Prepare Before April 2026 All Category, Blogs, Clinical Regulatory, regulatory / development / March 16, 2026 UK Clinical Trials Amendment Regulations 2025: What Sponsors Must Prepare Before April 2026 Read More »
GIDH and WHO Global Strategy on Digital Health 2027: How Countries Build Secure National Health Systems All Category, Blogs, regulatory / development / June 11, 2026 GIDH and WHO Global Strategy on Digital Health 2027: How Countries Build Secure National Health Systems Read More »
EU GMP Annex Updates 2026: N-Nitrosamines, ATMP GMP, and EMA’s Evolving Inspection Landscape All Category, GMP Compliance, Insights, Regulatory / development / March 11, 2026 EU GMP Annex Updates 2026: N-Nitrosamines, ATMP GMP, and EMA’s Evolving Inspection Landscape Read More »
FDA & EMA’s Joint Guiding Principles for Good AI Practice in Drug Development All Category, Blogs, Clinical Regulatory, regulatory / development / March 10, 2026 FDA & EMA’s Joint Guiding Principles for Good AI Practice in Drug Development Read More »
FDA QMSR Is Now in Effect: What the New Inspection Regime Means for Medical Device Manufacturers All Category, Blogs, GMP Compliance, Medical Device, regulatory / development / March 10, 2026 FDA QMSR Is Now in Effect: What the New Inspection Regime Means for Medical Device Manufacturers Read More »
Drug Safety Just Got Smarter: Inside the EMA’s 2026 GVP Updates Overhaul All Category, Blogs, Pharmacovigilance / development / March 2, 2026 Drug Safety Just Got Smarter: Inside the EMA’s 2026 GVP Updates Overhaul Read More »
Inspection Findings Related to Vendor Oversight in Pharmacovigilance All Category, Blogs, Pharmacovigilance / Nikita Saraswat / February 27, 2026 Inspection Findings Related to Vendor Oversight in Pharmacovigilance Read More »
Brazil-India Health Pact: What the New Drug Approvals and Regulatory Agreement Mean for Patients All Category, Clinical Regulatory, Insights, Regulatory / development / February 25, 2026 Brazil-India Health Pact: What the New Drug Approvals and Regulatory Agreement Mean for Patients Read More »
Risk Management Plans: Structure, Maintenance, and Regulatory Triggers for Updates All Category, Blogs, Pharmacovigilance / development / February 24, 2026 Risk Management Plans: Structure, Maintenance, and Regulatory Triggers for Updates Read More »
Regulatory Impact of Manufacturing Site Transfers All Category, Blogs, GMP Compliance, regulatory / development / February 20, 2026 Regulatory Impact of Manufacturing Site Transfers Read More »
